METHOD FOR NORMALISING FUNCTIONAL REACTIVITY OF CARDIOVASCULAR SYSTEM AMONG PATIENTS SUFFERING FROM ARTERIAL HYPERTENSION AT STAGE OF RECOVERY FORM CEREBRAL CIRCULATION DISORDER WITHOUT PARESES OR PARALYSES Russian patent published in 2010 - IPC A61K31/41 A61P9/12 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to cardiology, and concerns normalisation of cardiovascular system (CVS) functional reactivity among patients suffering from arterial hypertension at the stage of recovery form cerebral circulation disorder without pareses or paralyses. To that end, the state of CVS functional reactivity at psychoemotional stress is assessed by recording systolic, diastolic and average dynamic blood pressure. These data serve as the basis for determining functional reactivity index (FRI) prior to and after the stress, according to the following formula: FRI = (BP av.dyn. × heat rate)100 (conv. un.). If FRI value after stress rises by more than 20 conventional units, telmisartan and labetalole are administered in doses of 40 mg per day and 200 mg twice a day respectively.

EFFECT: method normalises functional reactivity of cardiovascular system and increases tolerance to psychoemotional stresses at the specified group of patients during a 2 month course of therapy.

2 ex